Reports
Sale
Global Proton Therapy Market Size, Share, Trends, Forecast: By Product Type: Systems, Software, Services; By Components: Proton Accelerator, Beam Delivery System, Nozzle, Image Viewers; Beam Transport System; Others; By Type; By Set-Up Systems; By Applications: By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Proton Therapy Market Outlook
The global proton therapy market size was valued at USD 1314.6 million in 2023, driven by the increasing incidence of cancer across the globe. The market is expected to grow at a CAGR of 12.4% during the forecast period of 2024-2032, with the values likely to rise from USD 1477 million in 2024 to USD 3749.8 million by 2032.
Proton Therapy: Introduction
Proton therapy is a type of radiation therapy that treats cancer with the help of positively charged ions (protons). It may also be used in the treatment of some noncancerous tumours or in conjunction with treatments like chemotherapy or surgery. Proton therapy has garnered high popularity owing to its minimal side effects when compared to conventional methods as doctors have better hold at controlling the site of energy accumulation.
Global Proton Therapy Market Analysis
The rising prevalence of cancer is a major factor leading to proton therapy market demand. While radiation has been a common part of cancer treatment, proton therapy is now gaining popularity owing to its minimal side effects when compared to traditional radiotherapy. It also facilitates the patients to continue with day-to-day lives owing to its painless nature.
The proton therapy market value is also anticipated to grow with increasing encouragement by regulatory authorities like American Society for Radiation Oncology (ASTRO) to apply the therapy on patients. Consequently, new age pharmaceutical companies are now dedicated to use the therapy. In September 2023, Shuttle Pharmaceuticals Holdings, Inc. conveyed their commitment to employ the treatment on patients at the Hampton University Proton Therapy Institute Prostate Cancer & Men's Health Fair.
The market is anticipated to grow with the rising set up proton system into the existing infrastructure. In October 2023, Hitachi launched Southeast Asia’s first proton therapy system in National Cancer Centre Singapore (NCCS). This system is equipped with four rotating gantries and a Real-time image Gating system for Proton Therapy (RGPT) to treat tumours in motion due to respiration. It is also enabled with advanced spot scanning technology to precisely irradiate tumors with compound shapes.
Global Proton Therapy Market Segmentation
Market Breakup by Product Type
- Systems
- Accelerators
- Cyclotrons
- Synchrotrons
- Beam Delivery
- Pencil Beam Scanning
- Passive Scattering
- Uniform Scanning
- Modulators
- Others
- Accelerators
- Software
- Services
Market Breakup by Components
- Proton Accelerator
- Cyclotrons
- Synchrotrons
- Synchrocyclotrons
- Linacs
- H-Minus Synchrotrons
- Separated Sector Cyclotrons
- Super-Conducting Cyclotrons
- Fast Cycling Synchrotron
- Beam Delivery System
- The Passive Scattering Technique
- Beam Scanning
- Nozzle
- Pencil Scanning Nozzle
- Single Scattering
- Double Scattering
- Uniform Scanning Nozzle
- Image Viewers
- Beam Transport System
- Patient Positioning System (PPS)
Market Breakup by Type
- Rotating Proton Therapy Systems
- Non-Rotating Proton Therapy Systems
Market Breakup by Set-Up Systems
- Multi-Room Systems
- Single-Room Systems
Market Breakup by Applications
- Treatment Applications
- Ediatric Cancer
- Tumours in the Base of the Skull
- Prostate Cancer
- Head and Neck Cancer
- Breast Cancer
- Lung Cancer
- Tumours Affecting Spine
- Eye Melanoma
- Lymphoma
- Pituitary Gland Tumours
- Others
- Research Applications
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centres
- Cancer Research Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Proton Therapy Market Overview
The United States alone is expected to record around 1,958,310 new cancer cases in 2023, hence, it is anticipated to hold a major part of the global proton therapy market share in upcoming years. Having a well-structured infrastructure that can easily adopt newer technologies is another essential component of the large market size. The region is experiencing validation from numerous upcoming companies which are willingly adapting to the latest techniques and devising better means of application.
Having several academic and healthcare institutions at home, Europe holds a massive market share as well. With the help of numerous awareness and educational campaigns, there is emphasis on educating the healthcare staff with the technical knowledge of using all the latest technologies.
The Asia Pacific region, on the other hand, is projected to encounter an upswing in the proton therapy market growth in the foreseeable future. With high national and foreign investments, emerging markets like India are continuously improving their research and healthcare infrastructure. Major healthcare companies are also investing in the Asian markets to leverage the easy availability of resources present in the region.
Global Proton Therapy Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Varian Medical Systems, Inc.
- IBA Group
- Hitachi, Ltd.
- Mevion Medical Systems, Inc.
- Sumitomo Heavy Industries, Ltd.
- Optivus Proton Therapy, Inc.
- ProTom International, Inc.
- Advanced Oncotherapy Plc.
- ProNova Solutions, LLC
- Mitsubishi Electric Corporation
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Components |
|
| Breakup by Type |
|
| Breakup by Set-Up Systems |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Proton Therapy Market Overview
3.1 Global Proton Therapy Market Historical Value (2017-2023)
3.2 Global Proton Therapy Market Forecast Value (2024-2032)
4 Global Proton Therapy Market Landscape
4.1 Global Proton Therapy Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Proton Therapy Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
5 Global Proton Therapy Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Proton Therapy Market Segmentation
6.1 Global Proton Therapy Market by Product Type
6.1.1 Market Overview
6.1.2 Systems
6.1.2.1 Accelerators
6.1.2.1.1 Cyclotrons
6.1.2.1.2 Synchrotrons
6.1.2.2 Beam Delivery
6.1.2.2.1 Pencil Beam Scanning
6.1.2.2.2 Passive Scattering
6.1.2.2.3 Uniform Scanning
6.1.2.3 Modulators
6.1.2.4 Others
6.1.3 Software
6.1.4 Services
6.2 Global Proton Therapy Market by Components
6.2.1 Market Overview
6.2.2 Proton Accelerator
6.2.2.1 Cyclotrons
6.2.2.2 Synchrotrons
6.2.2.3 Synchrocyclotrons
6.2.2.4 Linacs
6.2.2.5 H-Minus Synchrotrons
6.2.2.6 Separated Sector Cyclotrons
6.2.2.7 Super-Conducting Cyclotrons
6.2.2.8 Fast Cycling Synchrotron
6.2.3 Beam Delivery System
6.2.3.1 The Passive Scattering Technique
6.2.3.2 Beam Scanning
6.2.4 Nozzle
6.2.4.1 Pencil Scanning Nozzle
6.2.4.2 Single Scattering
6.2.4.3 Double Scattering
6.2.4.4 Uniform Scanning Nozzle
6.2.5 Image Viewers
6.2.6 Beam Transport System
6.2.7 Patient Positioning System (PPS)
6.3 Global Proton Therapy Market by Type
6.3.1 Market Overview
6.3.2 Rotating Proton Therapy Systems
6.3.3 Non-Rotating Proton Therapy Systems
6.4 Global Proton Therapy Market by Set-Up Systems
6.4.1 Market Overview
6.4.2 Multi-Room Systems
6.4.3 Single-Room Systems
6.5 Global Proton Therapy Market by Applications
6.5.1 Market Overview
6.5.2 Treatment Applications
6.5.2.1 Ediatric Cancer
6.5.2.2 Tumours In the Base of The Skull
6.5.2.3 Prostate Cancer
6.5.2.4 Head and Neck Cancer
6.5.2.5 Breast Cancer
6.5.2.6 Lung Cancer
6.5.2.7 Tumours Affecting Spine
6.5.2.8 Eye Melanoma
6.5.2.9 Lymphoma
6.5.2.10 Pituitary Gland Tumours
6.5.2.11 Others
6.5.3 Research Applications
6.6 Global Proton Therapy Market by End User
6.6.1 Market Overview
6.6.2 Hospitals
6.6.3 Ambulatory Surgical Centers
6.6.4 Cancer Research Institutes
6.6.5 Others
6.7 Global Proton Therapy Market by Region
6.7.1 Market Overview
6.7.2 North America
6.7.3 Europe
6.7.4 Asia Pacific
6.7.5 Latin America
6.7.6 Middle East and Africa
7 North America Proton Therapy Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Proton Therapy Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Proton Therapy Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Proton Therapy Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Proton Therapy Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Varian Medical Systems, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 IBA Group
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Hitachi, Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Mevion Medical Systems, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Sumitomo Heavy Industries, Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Optivus Proton Therapy, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 ProTom International, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Advanced Oncotherapy Plc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 ProNova Solutions, LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Mitsubishi Electric Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
18 Global Proton Therapy Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 1314.6 million in 2023 driven by the growing incidence of cancer across the globe.
The market is anticipated to grow at a CAGR of 12.4% during the forecast period of 2024-2032, likely to reach a market value of USD 3749.8 million by 2032.
The market demand is driven by the emphasis on finding better treatment alternatives that offer minimal side effects.
The current market trend is the increased set up of proton therapy systems in hospitals. In October 2023, Hitachi introduced Southeast Asia’s first proton therapy setup in National Cancer Centre Singapore (NCCS).
It is divided into systems which is further segmented into systems like accelerators which are further divided into cyclotrons, synchrotrons, beam delivery like pencil beam scanning, passive scattering, uniform scanning, modulators and others, along with software, and services.
The components include proton accelerators which is further divided into cyclotrons, synchrotrons, synchrocyclotrons, linacs, H-Minus synchrotrons, separated sector cyclotrons, super-conducting cyclotrons, fast cycling synchrotron beam delivery system like the passive scattering technique and beam scanning, nozzle which is further segmented into pencil scanning nozzle, single scattering, double scattering and uniform scanning nozzle, image viewers, beam transport system and lastly patient positioning system (PPS).
Common proton therapy systems include rotating and non-rotating proton therapy systems.
It is divided into multi-room and single-room systems.
Common application areas include treatment applications like pediatric cancer, tumors in the base of the skull, prostate cancer, head and neck cancer, breast cancer, lung cancer, tumors affecting spine, eye melanoma, lymphoma, pituitary gland tumors, along with research applications.
Major end users include hospitals, ambulatory surgical centers, cancer research institutes and others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Varian Medical Systems, Inc., IBA Group, Hitachi, Ltd., Mevion Medical Systems, Inc., Sumitomo Heavy Industries, Ltd., Optivus Proton Therapy, Inc., ProTom International, Inc., Advanced Oncotherapy Plc., ProNova Solutions, LLC, and Mitsubishi Electric Corporation.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER